Association study on MTHFR polymorphisms and meningioma in northern China

Gene. 2013 Mar 10;516(2):291-3. doi: 10.1016/j.gene.2012.12.019. Epub 2012 Dec 28.

Abstract

Background: Meningioma is the second most common primary tumor of the central nervous system, and multiple genetic and environmental factors contribute to its etiology. Methylene tetrahydrofolate reductase (MTHFR) is a pivotal enzyme in folate metabolism. We conducted a case-control study to investigate the association of the MTHFR gene and meningioma in a Han population in northern China.

Methods: We genotyped two SNPs (C677T and A1298C) using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). In this study 317 meningioma patients were compared to 320 normal controls. Data were analyzed by SPSS 13.0 and HaploView software.

Results: We found a significant difference in the frequency distribution of 677CC and 677TT between cases and control groups; another SNP exhibited no differences in any genotype between the two cohorts.

Conclusion: The results revealed that variations of the MTHFR gene were associated with meningioma; this finding indicates that the MTHFR gene potentially plays an important role in the pathogenesis of meningioma in the Northern Chinese Han population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asian People / genetics
  • Case-Control Studies
  • China / epidemiology
  • Female
  • Gene Frequency
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Meningeal Neoplasms / epidemiology
  • Meningeal Neoplasms / ethnology
  • Meningeal Neoplasms / genetics*
  • Meningioma / epidemiology
  • Meningioma / ethnology
  • Meningioma / genetics*
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Middle Aged
  • Polymorphism, Single Nucleotide* / physiology

Substances

  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)